Neurogene Inc (NGNE) financials · $286.5M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Neurogene Inc (NGNE) $286.5M cap.
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | — | $925.00K | |
| Operating Income | −$103.33M | −$82.61M | |
| Net Income | −$90.35M | −$75.14M | |
| EPS (Diluted) | −$4.24 | −$4.28 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $288.60M | $335.73M | |
| Current Assets | $271.77M | $315.92M | |
| Cash & Equivalents | $103.84M | $136.59M | |
| PP&E | $12.79M | $15.42M | |
| Total Liabilities | $23.72M | $25.36M | |
| Current Liabilities | $16.41M | $15.16M | |
| Shareholders' Equity | $264.89M | $310.38M | |
| Retained Earnings | −$352.65M | −$262.30M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$77.17M | −$70.60M | |
| CapEx | $1.18M | $808.00K | |
| Investing Cash Flow | $14.00M | −$125.26M | |
| Financing Cash Flow | $30.43M | $184.07M | |
| Net Change in Cash | −$32.74M | −$11.79M | |
| Free Cash Flow | −$78.36M | −$71.41M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is NGNE P/E and revenue?
Neurogene Inc (NGNE) $286.5M cap.
What is NGNE revenue?
NGNE income-statement cache has no revenue figure yet.
Is NGNE profitable?
Neurogene Inc last cached net income is -$90.4M (FY2025).
What are NGNE total assets?
Neurogene Inc last cached total assets are $288.6M (FY2025).
What is NGNE free cash flow?
Neurogene Inc last cached free cash flow is -$78.4M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.